81 to 90 of 349 Results
Jul 20, 2023 - Virus Epidemiology and Control (VEC) Dataverse
Lambisia, Arnold W.; Murunga, Nickson; Mutunga, Martin; Cheruiyot, Robinson; Maina, Grace; Makori, Timothy; Nokes, D.James; Agoti, Charles N., 2023, "Replication Data for: Temporal changes in the positivity rate of common enteric viruses among paediatric admissions in coastal Kenya, in the period spanning the COVID-19 pandemic, 2019-2022", https://doi.org/10.7910/DVN/EG6MEH, Harvard Dataverse, V1, UNF:6:prw/VZIIJHN4aFHKLaZ63w== [fileUNF]
This is a replication dataset for the manuscript titled "Temporal changes in the positivity rate of common enteric viruses among paediatric admissions in coastal Kenya, in the period spanning the COVID-19 pandemic, 2019-2022." The main dataset is part of long-term surveillance of enteric viruses associated with diarrhoea. These datasets are part of... |
Jul 3, 2023 - Virus Epidemiology and Control (VEC) Dataverse
Mwanga, Mike J.; Lambisia, Anorld W.; Morobe, John M.; Murunga, Nickson; Cheruiyot, Robinson; Moraa, Edidah O.; Ndwiga, Leonard; Mutunga, Martin; Laura,Guzman-Rincon; Musyoki, Jennifer; Sande, Charles; Mwangangi, Joseph; Bejon, Philip; Oyier, Isabella Lynette-Ochola; Nokes, D. James; Agoti, Charles N.; Nyiro, Joyce; Githinji, George, 2023, "Replication Data for: A new Omicron lineage with Spike Y451H mutation dominating a new COVID-19 wave in Kilifi, Coastal Kenya: March-May 2023", https://doi.org/10.7910/DVN/ZMGR5P, Harvard Dataverse, V2, UNF:6:q6pTyD3YKStTyrKYHjqbfg== [fileUNF]
This dataset is part of a study that investigated the genomic epidemiology of SARS-CoV-2 in Kenya. This dataset contains results of samples positive for SARS-COV-2 by real-time PCR for the period 1st January to 27th May 2023 from Kilifi. Aside from the samples tested and results of the tests, it also contains the patients’ sociodemographic characte... |
Jun 19, 2023 - Clinical Information Network (CIN) Group Dataverse
Kigo, Joyce; Kamau, Stephen; Akech, Samuel; Dunsmuir, Dustin; Pillay, Yashodani; Ansermino, J. Mark; Ouma, Mary; Kimutai, David; Mohamed, Ismael; Chege, Mary; Thuranira, Lydia, 2023, "Replication Data for: Triage and management of sepsis in children using the point-of care Pediatric Rapid Sepsis Trigger (PRST) tool", https://doi.org/10.7910/DVN/942AND, Harvard Dataverse, V2, UNF:6:mIxOcSZTdlhDtgX1iFrv6A== [fileUNF]
This is a replication dataset for the manuscript titled "Triage and management of sepsis in children using the point-of care pediatric Rapid Sepsis Trigger(PRST) tool." The data was collected as part of PRST study phase 1 which was carried out in Mbagathi County Hospital (Hospital 1)and Kiambu teaching and Referral hospital(Hospital 2) between Febr... |
Jun 19, 2023 - Invasive Bacterial Disease Research Group Dataverse
Karia, Boniface; Kagucia, E. Wangeci, 2022, "Replication Data for: SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022", https://doi.org/10.7910/DVN/L4AUEG, Harvard Dataverse, V2, UNF:6:/AzedQo06sVkNbPGEqgI8w== [fileUNF]
This is a replication dataset underlying the findings described in the manuscript entitled "SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February - December 2022" and submitted to Influenza and Other Respiratory Viruses. |
Jun 7, 2023
Kimotho, John; Sein, Yiakon; Sayed, Shahin; Shah, Reena; Mwai, Kennedy; Saleh, Mansoor; Wanjiku, Perpetual; Mwacharo, Jedidah; Nyagwange, James; Karanja, Henry; Kutima, Bernadette; Gitonga, John; Mugo, Daisy; Karanu, Ann; Moranga, Linda; Oluoch, Vivian; Shah, Jasmit; Mutiso, Julius; Mburu, Alfred; Nneka, Zaitun; Betti, Peter; Mutinda, Wanzila Usyu; Abdi, Abdirahman Issak; Bejon, Philip; Ochola-Oyier, Lynette Isabella; Warimwe, George M.; Nduati, Eunice; Ndungu, Francis M., 2022, "Replication Data for: Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severity", https://doi.org/10.7910/DVN/6KW9U1, Harvard Dataverse, V6, UNF:6:WDqy7xU/HTgwRNAerPTu+Q== [fileUNF]
This is a replication dataset for the manuscript titled: "Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severity." |
Jun 2, 2023 - Human Genetic Factors (HGF) Group
Opi, Herbert; Ndila, Carolyne M.; Uyoga, Sophie; Macharia, Alex W.; Fennell,Clare; Ochola, Lucy B.; Nyutu,Gideon; Siddondo,Bethsheba R.; Ojal, John; Shebe, Mohammed; Awuondo, Kennedy O.; Mturi, Neema; Peshu, Norbert; Tsofa, Benjamin; Band, Gavin; Maitland, Kathryn; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Williams, Thomas N.; Rowe, J. Alexandra, 2023, "Replication Data for: Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria", https://doi.org/10.7910/DVN/A5KILM, Harvard Dataverse, V1
We present here the replication dataset used to generate results for the manuscript titled "Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria". The dataset included here comprise of clinical, epidemiological and multiple host genotype (including ABO blood group) data from a cases co... |
May 31, 2023 - International AIDS Vaccine Initiative (IAVI)
Sanders, Eduard, 2023, "Use of Bexsero immunisation to detect cross reactive antigens and anti-gonococcal antibodies in key populations in Kenya", https://doi.org/10.7910/DVN/2OCJWU, Harvard Dataverse, V1
Gonorrhoea is a sexually transmitted infection that can infect both men and women. It can cause infections in the genitals, rectum, and throat. It is a very common infection, especially among young people aged 18-25 years. Meningococcal disease and gonorrhoea are caused by bacteria that are closely related but cause different diseases that are spre... |
Apr 27, 2023 - Clinical Information Network (CIN) Group Dataverse
Tuti, Timothy; Muinga, Naomi; Mwaniki, Paul, 2023, "Replication Data for: Evaluating the documentation of vital signs following implementation of a new comprehensive newborn monitoring chart in 19 hospitals in Kenya: A time series analysis", https://doi.org/10.7910/DVN/6WBRVC, Harvard Dataverse, V1, UNF:6:45OuEUGEAqqUZKRav2hTOg== [fileUNF]
A comprehensive newborn monitoring chart was co-designed with stakeholders and implemented in newborn wards of 19 public hospitals in Kenya within the clinical information network. To understand its effect on documentation, we collected data over a 2-year period (September 2019 to October 2021) pre- and post-implementation. Data on frequency of doc... |
Apr 20, 2023 - Biosciences Dataverse
Maia, Marta F.; Kamau, Yvonne; Tuwei, Mercy; Ominde, Kelly; Ngama, Mwanajuma; Karisa, Jonathan; Babu, Lawrence; Muturi, Martha; Lewa,Frida; Mure, Festus; Mwatasa, Mwaganyuma; Wanjiku, Caroline; Adetifa, Jane; Kern, Charlotte; Duthaler, Urs; Hammann,Felix; Rabinovich,Regina; Chaccour, Carlos, 2023, "Data for: Mosquitocidal effect and pharmacokinetics of different ivermectin dose regimens in preparation for BOHEMIA cluster randomized controlled trial", https://doi.org/10.7910/DVN/SOBL4B, Harvard Dataverse, V2
The aim of the trial was to compare the pharmacokinetics and mosquito-killing effect of 300 mcg/kg of IVM given on three consecutive days to 400 mcg/kg of IVM given once. The trial also evaluated how the two treatments differed from albendazole in terms of mosquito survival Mosquitocidal effect and pharmacokinetics of different ivermectin dose regi... |
Apr 13, 2023 - Biosciences Dataverse
Cheruiyot, Stanley; Orindi, Benedict O.; Warimwe, George M., 2023, "Data for: A phase Ib/II single-blinded, randomised, controlled study to determine safety, immunogenicity and efficacy of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in adults in Kenya", https://doi.org/10.7910/DVN/L4NX9M, Harvard Dataverse, V3, UNF:6:Hrsr33WVvMVkOXLz/cPrcA== [fileUNF]
The dataset contains information on demographics, safety and immunogenicity collected to evaluate whether the ChAdOx1 nCoV-19 vaccine is safe, elicits good immune responses and protects Kenyan adults from COVID19. The persistence of these immune responses was investigated up to 12 months following immunization with a single dose of vaccine at Day 0... |